Health
Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult – News-Medical.Net
Albumedix Ltd. (‘Albumedix’), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered…
Albumedix Ltd. (‘Albumedix’), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
This agreement reflects the continued efforts of Albumedix to engage with the industry and expand upon its knowledge…
-
Noosa News15 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News21 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Business20 hours agoAre BHP shares are buy after its results?
-
General24 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply